mRNA |
BRD-K84807411 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
0.03 |
mRNA |
BI-2536 |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.03 |
mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
0.081 |
0.03 |
mRNA |
KIN001-244 |
GDSC1000 |
pan-cancer |
AAC |
0.069 |
0.03 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.077 |
0.03 |
mRNA |
VX-680 |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.03 |
mRNA |
BRD-K24690302 |
CTRPv2 |
pan-cancer |
AAC |
0.08 |
0.03 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.077 |
0.04 |
mRNA |
Salubrinal |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.04 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.072 |
0.04 |